TFE3 and sarcoma: Nevertheless, the fact that it was successful for most entities, including the first ETV6::NTRK3-driven model and orthotopic ASPSCR1::TFE3 model outside the cranial vault25, clearly suggests that this method is applicable to many other sarcoma subtypes.